|
ACO1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.57760000002649E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.44879999999892E-06 |
| Normal-vs-Stage2 |
3.74710000000666E-05 |
| Normal-vs-Stage3 |
2.37449999999084E-05 |
| Normal-vs-Stage4 |
2.49889999999198E-05 |
| Stage1-vs-Stage2 |
4.210400E-01 |
| Stage1-vs-Stage3 |
3.804000E-01 |
| Stage1-vs-Stage4 |
9.804600E-01 |
| Stage2-vs-Stage3 |
9.606200E-01 |
| Stage2-vs-Stage4 |
5.156400E-01 |
| Stage3-vs-Stage4 |
5.309200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.90150000004097E-06 |
| Normal-vs-AfricanAmerican |
2.37599999999283E-05 |
| Normal-vs-Asian |
2.747500E-02 |
| Caucasian-vs-AfricanAmerican |
5.582800E-01 |
| Caucasian-vs-Asian |
9.610400E-01 |
| AfricanAmerican-vs-Asian |
8.870200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.08390000000502E-06 |
| Normal-vs-Female |
6.16430000000001E-05 |
| Male-vs-Female |
6.902400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.44760000000155E-05 |
| Normal-vs-Extreme_Weight |
7.85679999948385E-07 |
| Normal-vs-Obese |
1.68082999999486E-05 |
| Normal-vs-Extreme_Obese |
3.31030000000343E-06 |
| Normal_Weight-vs-Extreme_Weight |
1.282180E-01 |
| Normal_Weight-vs-Obese |
6.494200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.808000E-01 |
| Extreme_Weight-vs-Obese |
1.995550E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.582400E-01 |
| Obese-vs-Extreme_Obese |
4.587800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.43950000000149E-05 |
| Normal-vs-Age(41-60Yrs) |
1.66357999999978E-05 |
| Normal-vs-Age(61-80Yrs) |
2.21479999995555E-06 |
| Normal-vs-Age(81-100Yrs) |
6.28579999999435E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.505600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.939400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.843000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.813200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.177800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.680010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.20359999999931E-06 |
| Normal-VS-Type2 PRCC |
1.410170E-04 |
| Normal-VS-KIRP CIMP |
3.63719999996182E-06 |
| Normal-VS-Unclassified PRCC |
4.31280000000589E-05 |
| Type1 PRCC-VS-Type2 PRCC |
9.835800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.650000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.946400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.045020E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.496600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.074600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.46889999999867E-05 |
| Normal-vs-N1 |
2.27529999996534E-06 |
| Normal-vs-N2 |
4.7535000002874E-07 |
| N0-vs-N1 |
1.663440E-01 |
| N0-vs-N2 |
3.261400E-03 |
| N1-vs-N2 |
2.763800E-01 |
|
|
